Kilitch Drugs (India) vs Nifty 50: Returns Compared

Kilitch Drugs (India) vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Kilitch Drugs (India) trades on the NSE under the symbol KILITCH, and its 1M return of +25.08% compares with the Nifty 50's -5.97% over the same period.

The Kilitch Drugs (India) vs Nifty 50 comparison matters because Kilitch Drugs (India) is a single stock exposed to its own sector and company-specific developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Kilitch Drugs (India) share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year, 3 years, using NSE closing data.

Also read – Kaveri Seed Company vs Nifty 50: Share Price Performance Compared

Click Here – Get Free Investment Predictions

Kilitch Drugs (India) vs Nifty 50: Performance at a Glance

The table below sets out Kilitch Drugs (India) vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 1 October 2026.

Time Frame	Kilitch Drugs (India) Return	Nifty 50 Return	Difference
1 Month	+25.08%	-5.97%	+31.04% pp
3 Months	+8.29%	-6.43%	+14.72% pp
6 Months	+53.86%	-0.41%	+54.26% pp
1 Year	+23.97%	-8.92%	+32.89% pp
3 Years	+65.6% (Kilitch Drugs (India))	+15.19% (Nifty 50)	+50.41% pp

On the Kilitch Drugs (India) vs Nifty 50 scorecard, Kilitch Drugs (India) has stayed ahead of the index over the most recent one-year window. Over the longer term the stock has also stayed ahead of the index, a pattern that reflects its underlying business momentum rather than a single quarter's swing.

Check the Univest Screener for live Kilitch Drugs (India) and Nifty 50 data

Why the Kilitch Drugs (India) vs Nifty 50 Gap Exists

Kilitch Drugs (India)'s stock can move quite differently from the Nifty 50 because it carries concentrated exposure to its own sector and business cycle, unlike the index which blends 50 companies across banking, IT, energy and consumer sectors. This is the main driver of the gap seen in the Kilitch Drugs (India) vs Nifty 50 return table above.

A second factor behind the Kilitch Drugs (India) vs Nifty 50 divergence is valuation and trading liquidity. Company-specific news, quarterly results and sector sentiment can move Kilitch Drugs (India)'s price sharply in either direction over short periods, while the Nifty 50's return reflects the blended earnings trajectory of its constituents and is far less exposed to any single stock's swings.

Download the Univest iOS App or Univest Android App to track Kilitch Drugs (India) and Nifty 50 live on the go.

Kilitch Drugs (India) vs Nifty 50: Has Kilitch Drugs (India) Beaten the Benchmark?

Kilitch Drugs (India) has beaten the Nifty 50 over the past year, gaining +23.97% against the index's -8.92% over the same period.

Also read – Kewal Kiran Clothing vs Nifty 50: Share Price Performance Compared

Risks of the Kilitch Drugs (India) vs Nifty 50 Comparison

Reading too much into a Kilitch Drugs (India) vs Nifty 50 comparison has real limitations that investors should weigh before drawing conclusions. Kilitch Drugs (India) carries concentrated business and sector risk that a diversified index does not, and its trading volumes and price swings can differ meaningfully from the Nifty 50's more liquid, blended profile. A stock's 52-week range of Rs 117.25 to Rs 232.50 also shows the kind of volatility that a single-stock investment carries relative to a broad index.

Conclusion

Kilitch Drugs (India) vs Nifty 50 highlights how a single stock's return path can differ from a diversified benchmark over different time horizons. Investors weighing the Kilitch Drugs (India) vs Nifty 50 record should factor in Kilitch Drugs (India)'s volatility, liquidity and sector concentration alongside its return history, and consult a SEBI-registered advisor before making an allocation decision.

Has Kilitch Drugs (India) outperformed the Nifty 50 in the last year?

Ans. Yes. Kilitch Drugs (India) gained +23.97% over the past year while the Nifty 50 returned -8.92% over the same period, based on NSE closing prices to 1 October 2026.

How does Kilitch Drugs (India) vs Nifty 50 look over 3 years?

Ans. Over three years Kilitch Drugs (India) has returned +65.6% compared with the Nifty 50's +15.19%, so in the Kilitch Drugs (India) vs Nifty 50 comparison the stock has been ahead over this horizon.

What is the Kilitch Drugs (India) share price today compared to Nifty 50?

Ans. Kilitch Drugs (India) share price stood at Rs 213.32 on NSE, while the Nifty 50 traded at 22,620.45 based on the same closing data window.

What is the 52-week high and low of Kilitch Drugs (India)?

Ans. Kilitch Drugs (India)'s 52-week high is Rs 232.50 and its 52-week low is Rs 117.25, based on NSE data.

Why does Kilitch Drugs (India) show bigger price swings than the Nifty 50?

Ans. Kilitch Drugs (India) carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies, so company-specific news moves Kilitch Drugs (India)'s price more sharply than the diversified index, a key reason the Kilitch Drugs (India) vs Nifty 50 return gap varies across time frames.

Is Kilitch Drugs (India) a good long-term investment compared to a Nifty 50 index fund?

Ans. Kilitch Drugs (India)'s suitability depends on an investor's risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund; long-term investors should weigh the Kilitch Drugs (India) vs Nifty 50 return history alongside the company's fundamentals and consult a SEBI-registered advisor.